Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
In the competitive renewable fuels industry, Aemetis holds a niche in circular bioeconomy solutions, leveraging facilities in California and India. Its exposure to government incentives like Low Carbon Fuel Standard (LCFS) credits and emerging federal 45Z clean fuel production tax credits (tax credits for low-emission fuels) underpins revenue. From what I see, the strong fundamentals in scaling RNG and plant upgrades explain the recent price strength, as these initiatives promise sustained cash flow amid rising demand for decarbonization in transportation.
Over the last 30 days, AMTX stock delivered a robust +strong performance, rising from approximately $1.40 in early March 2026 to a close of $3.19 on March 31, 2026. The movement was volatile and trend-driven, with sharp rallies post-Q4 earnings on March 12, peaking near $3.60 before minor pullbacks, reflecting high trading volume exceeding 2 million shares on key days.
For the past quarter, the stock advanced around +100%, from roughly $1.59 in early January 2026 to the current level. Performance featured steady upward momentum interspersed with volatility, range-bound in low $1s early on before breaking out on operational news, aligning with broader renewable sector trends. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The 30-day surge was primarily propelled by Aemetis' Q4 and full-year 2025 earnings release on March 12, highlighting a 61% year-over-year increase in dairy RNG production and $12.2 million in net income from the biogas segment. Despite missing revenue estimates with $43.31 million versus expectations, the market focused on forward guidance: a mechanical vapor recompression (MVR) upgrade at the Keyes ethanol plant poised to add $32 million in annual cash flow upon 2026 completion.
India biodiesel deliveries resumed under a $24 million allocation from oil marketing companies, boosting sentiment. Analyst updates, like Stonegate Capital's coverage, and CEO Eric McAfee's lifetime achievement award in the bioeconomy amplified positive market sentiment. Sector tailwinds from clean fuel policies, including California's year-round E15 ethanol approval, further supported the rally amid heightened trading volume and short interest reduction. One thing that stands out is how these operational wins have shifted investor focus.
The quarterly uptrend stemmed from sustained operational progress in RNG and biofuels. Dairy biogas digesters scaled, turning profitable and generating strong EBITDA potential, countering ethanol segment cyclicality. Broader macroeconomic support for renewables—rising LCFS credit values, federal incentives via the "One Big Beautiful Bill," and demand for low-carbon trucking/aviation fuels—provided tailwinds.
India operations gained traction with biodiesel contracts, diversifying revenue. Institutional behavior shifted positively post-earnings, with high short interest unwind contributing to momentum. Competitive positioning strengthened via carbon intensity reductions, though debt levels and liquidity risks tempered gains. Cumulative impact favored growth narratives over near-term losses ($77 million full-year net loss). In my view, this balance of progress and challenges is worth monitoring closely.
I’ve found Tickeron’s Trending AI Robots particularly useful in my analysis of stocks like AMTX. This page showcases the platform's top-performing AI trading bots from hundreds available, which analyze and trade thousands of tickers across various strategies, timeframes, and performance metrics like win rate, profit factor, and drawdown. These curated bots represent the most relevant and successful ones based on recent market conditions, offering insights into automated trading patterns. Whether momentum-based, mean-reversion, or sector-specific, they provide transparent backtested and live results that help refine my own trading decisions.
Investors should monitor upcoming Q1 2026 earnings for RNG production updates and MVR upgrade progress. Industry trends in sustainable aviation fuel (SAF) demand and biogas expansion could influence sentiment. Macro factors like federal 45Z credit implementation, LCFS credit prices, and interest rates impacting capex remain key.
Strategic developments, including dairy digester network growth and India biodiesel scaling, alongside risks from commodity price volatility (corn, dairy waste) and $300 million debt load, warrant attention. Potential catalysts include new partnerships or policy expansions; watch regulatory changes in renewable mandates. I’m watching these elements closely as they could shape the next moves.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 21 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMTX advanced for three days, in 193 of 238 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
AMTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on September 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMTX as a result. In 74 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for AMTX turned negative on September 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 36 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
AMTX moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AMTX crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for AMTX entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. AMTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.282) is normal, around the industry mean (2.372). P/E Ratio (-1.465) is within average values for comparable stocks, (-17.554). AMTX's Projected Growth (PEG Ratio) (19.780) is very high in comparison to the industry average of (1.548). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.555) is also within normal values, averaging (48.960).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a producer of renewable chemicals and fuels using patented microbes and processes
Industry ChemicalsSpecialty